Dr. Datsons Labs jumped 7.35% to Rs 11.83 at 11:45 IST on BSE after the company's board will meet on 15 December 2014, to discuss on letter of interest received from Leaders Group Asia for acquiring majority stake in the company.
The announcement was made by the company after market hours yesterday, 8 December 2014,
Meanwhile, the BSE Sensex was down 63.97 points, or 0.23%, to 28,055.43.
On BSE, so far 5.57 lakh shares were traded in the counter, compared with an average volume of 4.82 lakh shares in the past one quarter.
The stock hit a high of Rs 12.20 and a low of Rs 11.20 so far during the day. The stock hit a 52-week high of Rs 86.95 on 28 January 2014. The stock hit a 52-week low of Rs 8.91 on 28 August 2014.
The stock had underperformed the market over the past one month till 8 December 2014, falling 18.79 % compared with 0.9% rise in the Sensex. The scrip had also underperformed the market in past one quarter, declining 24.1% as against Sensex's 2.93% rise.
More From This Section
The small-cap pharma firm has an equity capital of Rs 105.26 crore. Face value per share is Rs 10.
The board of directors on that day will also discuss on demerger of Business of Active Pharmaceutical Ingredients (API) and Formulation of the company.
Dr. Datsons Labs' net profit fell 98.9% to Rs 0.02 crore on 10.3% decline in total income to Rs 118.40 crore in Q2 Septemeber 2014 over Q2 September 2013.
Powered by Capital Market - Live News